CN104496843B - Method for synthesizing ubenimex - Google Patents
Method for synthesizing ubenimex Download PDFInfo
- Publication number
- CN104496843B CN104496843B CN201410742120.9A CN201410742120A CN104496843B CN 104496843 B CN104496843 B CN 104496843B CN 201410742120 A CN201410742120 A CN 201410742120A CN 104496843 B CN104496843 B CN 104496843B
- Authority
- CN
- China
- Prior art keywords
- tert
- hydroxy
- butoxycarbonylamino
- phenyl
- evaporated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
The invention discloses a method for synthesizing ubenimex. The method comprises the following steps: by taking D-Boc-phenyl alaninal as a raw material, sequentially preparing hydroxynitrile, carrying out a nitrile hydrolysis reaction, performing amino protection, performing chiral resolution on (2RS,3R)-3-tert-butoxyacylamino-2-hydroxy-4-phenylbutyric acid, and synthesizing (S)-phenyl-2-((2S,3R)-3-(tert-butoxyacylamino)-2-hydroxy-4-phenylbutyramide)-4-mevalonate, thereby synthesizing the ubenimex. According to the synthetic method disclosed by the invention, the defect that the resolving agent used in the conventional synthetic method is high in toxicity (such as strychnine) or high in price (such as alpha-phenylethylamine) is overcome, the synthetic method is simple in steps and low in cost, and use of reagents such as strychnine is avoided; and moreover, a dextro-amino compound is taken as the chiral resolution agent, the price is low, the operation is simple, the stirring and recrystallization time is shortened, and the synthetic efficiency is greatly improved.
Description
Technical field
The invention belongs to the synthesis field of chemicals, it is related to a kind of synthetic method of antineoplastic and in particular to one
Plant the synthetic method of ubenimex.
Background technology
Ubenimex (Ubenimex), its medicine name is bestatin;Another name:By Bi Nimei;Trade name:Hundred scholars are glad;
Chemical name:N- [(2S, 3R) -3- amino -2- hydroxyl -4- benzene butyryl]-L-Leu.Ubenimex is 1976 by Japanese scholars
Mei Ze shore husband separates, from the nutrient solution of the netted streptomycete of olive, the small molecule dipeptide compound obtaining, and can suppress multiple aminopeptidases
Activity, such as APN, APB, APP, LAP and MetAP.Additionally, ubenimex can also strengthen host immune function, suppress tumor group
Knit Angiogenesiss, thus suppressing invasion and attack and the transfer of tumour.1987, ubenimex was as cancer therapy drug on Japan is formal
City.
Clinical studies show, ubenimex is the cytotoxic activity by antineoplastic known to raising, thus realizing it
Curative effect in treatment of cancer.Chemotherapy, the auxiliary treatment of radiotherapy and senile immunologic function that this product is used for tumor patient lack
The disease such as sunken.Indication includes leukaemia, Huppert's disease, RAEB, and other solid tumor.With
The increase of global consumption, obviously can not meet the demand of drug market by fermenting and producing ubenimex.Therefore, pharmacy work
Industry research team and scientific research and academic institution take great effort, to find the production practicable route of this medicine.
Ubenimex complex structure, it comprises a peptide bond, and this key is very sensitive to soda acid, and unstable at high temperature
Fixed.Additionally, it comprises three asymmetric carbon atoms:C2, C3 and C5.Therefore, 7 stereoisomers in it and other coexist in theory.
So properly forming 3 chiral centres, and keep the complete of its chirality so that the synthesis of ubenimex has greatly has
Challenge.
1976, the reported first such as Suda ubenimex fully synthetic, its key technology is to improve chipal compounds
Optical purity.Hereafter, in more than 30 year, the synthesis of ubenimex is always the focus of chemist and pharmacy corporation.Substantial amounts of
The document report synthesis of ubenimex, from traditional Split Method to asymmetric syntheses, then arrives biological catalysis.However, because
Asymmetric syntheses relatively costly, biological catalysis at present also in laboratory stage, industrial use now remain biography
The Split Method of system.The Split Method of document report mainly has two classes:The first kind, by chromatographing post separation, this method is big due to adsorbance,
Greatly reduce total recovery;Equations of The Second Kind, by chiral resolving agent separate, this method be at present industrial production chipal compounds
Common method.However, the resolving agent of current document report or toxicity too big (as strychnia) or expensive (α-benzene second
Amine).
Chinese patent CN 101891647 A discloses a kind of preparation method of ubenimex, and described preparation method includes
Prepare highly purified key intermediate (2S, 3R) -3- ammonia with 1B, L-arginine or L-Histidine as resolution reagent
Base -2- hydroxy-4-phenyl butyric acid and be used EDCI/HOAt to keep peptide chain to form the chirality of middle C-5 as condensing agent.The present invention
Efficiently solve that existing resolving agent exists can not completely will (2S, 3R) -3- amino -2- hydroxy-4-phenyl butyric acid and (2R,
3S) the problem of the detached problem of -3- acetylaminohydroxyphenylarsonic acid 2- hydroxy-4-phenyl butyric acid and amide condensed middle racemization.The present invention exists
Following defect:In the present invention, the synthesis step of ubenimex is loaded down with trivial details, and the reaction time is long, and intermediate product is many, high cost, thus efficiency
Low;, as resolution reagent, stirring, recrystallization time are longer afterwards, lead to reaction efficiency for 1B, L-arginine or L-Histidine
Low.
Content of the invention
The purpose of the present invention is exactly that this method has in order to solve the above problems, provide a kind of synthetic method of ubenimex
Have the advantages that cheap, simple to operate.
To achieve these goals, the present invention adopts the following technical scheme that:
A kind of synthetic method of ubenimex, with D-Boc- phenylpropyl alcohol ammonium aldehyde ((R)-(+) -2- (tertbutyloxycarbonylamino) -
3- hydrocinnamicaldehyde) it is raw material, sequentially pass through the preparation of hydroxyl nitrile, the protection of itrile group hydrolysis and amino, (2RS, 3R) -3- uncle
The chiral resolution of fourth oxanamide base -2- hydroxy-4-phenyl butyric acid, (S)-phenyl 2- ((2S, 3R) -3- (tert-butoxycarbonylamino) -2-
Hydroxyl -4- fenbutyramidum base) -4- methylpent acid esters synthesis, the synthesis of ubenimex;
The preparation of described hydroxyl nitrile is specially:D-Boc- phenylpropyl alcohol ammonium aldehyde is dissolved in ethyl acetate, adds water, NaHSO3, instead
Answer 8~15h (preferably 10h), phase of fetching water, add NaCN in aqueous phase, continue reaction 8~15h (preferably 10h), with ethyl acetate
Extraction, washing, organic phase is dried, filters, be evaporated (2RS, 3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyronitrile, its
Middle D-Boc- phenylpropyl alcohol ammonium aldehyde:Ethyl acetate:Water:NaCN:NaHSO3=1:2~3:8~12:0.3~0.8:0.1~0.4, g:
ml:ml:g:g;
The protection of itrile group hydrolysis and amino is specially:By (2RS, 3R) -3- tert-butoxycarbonylamino -2- hydroxyl -4- benzene
Base butyronitrile adds 2~4 times amount (i.e.:Dioxane concentrated hydrochloric acid mixed liquor volume ml be (2RS, 3R) -3- tert-butoxycarbonylamino -
The multiple of 2- hydroxy-4-phenyl butyronitrile quality g) dioxane concentrated hydrochloric acid mixed liquor (v/v=1/0.8~2), backflow overnight,
It is dissolved in water after being evaporated, is washed with ethyl acetate, 3N NaOH solution adjusts pH to 11~12, under ice bath, drip 4~6 times amount (i.e.:Drip
Plus oxolane volume (ml) is 4-6 times of raw material D-Boc- phenylpropyl alcohol ammonium aldehyde weight (g)) containing dimethyl dicarbonate butyl ester
(Boc)2Tetrahydrofuran solution (the w/v=1g of O:3~6ml) after temperature reaction 10~15h (preferably 12h), THF is evaporated off, with oil
Ether is washed, and 1N HCl adjusts pH to 2~3, and ethyl acetate extracts, and is dried, and filters, is evaporated, recrystallizes (2RS, 3R) -3- tertiary fourth oxygen acyl
Amido -2- hydroxy-4-phenyl butyric acid;
The chiral resolution of (2RS, 3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyric acid is specially:By (2RS, 3R)-
3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyric acid is dissolved in absolute ethyl alcohol, adds (1S, 2S) -2- amino -1- (4- nitrobenzene
Base) propane -1,3- glycol, let cool crystallization after 50~70 DEG C (preferably 60 DEG C) stirrings 1.5~2.5h (preferably 2h), filter, will tie
Crystalline substance is adjusted after PH to 2~3 with 1N HCl with ethyl acetate extraction after being dissolved in water, is dried, filters, be evaporated, obtain the tertiary fourth of (2S, 3R) -3-
Oxanamide base -2- hydroxy-4-phenyl butyric acid, wherein (2RS, 3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyric acid:Anhydrous
Ethanol:(1S, 2S) -2- amino -1- (4- nitrobenzophenone) propane -1,3- glycol=1:8~13:1~2, g:ml:g;
(S)-phenyl 2- ((2S, 3R) -3- (tert-butoxycarbonylamino) -2- hydroxyl -4- fenbutyramidum base) -4- methylpent acid esters
Synthesis be specially:By (2S, 3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyric acid be dissolved in 4- (dimercapto methylene) -
2- methyl -6- (to dimethylaminostyryl) -4H- pyrans (DCM) or anhydrous methylene chloride, (preferably DCM), add under ice bath
1- hydroxy benzo triazole (HoBt), 1- ethyl-(3- dimethylaminopropyl) carbodiimide hydrochloride (EDCI), 20~
40min (preferably 30min) adds L-Leu benzyl ester tosilate and triethylamine afterwards, and room temperature reaction overnight, is divided with quality
Number is 10% citric acid, saturation NaHCO3, saturated common salt is washed, and is dried, and filters, is evaporated (S)-phenyl 2- ((2S, 3R) -3-
(tert-butoxycarbonylamino) -2- hydroxyl -4- fenbutyramidum base) -4- methylpent acid esters, wherein (S)-phenyl 2- ((2S, 3R) -3- (uncle
Fourth oxanamide base) -2- hydroxyl -4- fenbutyramidum base) -4- methylpent acid esters:DCM:HoBt:EDCI:L-Leu benzyl ester is to first
Benzene sulfonate:Triethylamine=1:10~20:0.2~0.8:0.3~0.9:1~2:0.2~0.8, g:ml:g:g:g:ml;
The synthesis of ubenimex is specially:By (S)-phenyl 2- ((2S, 3R) -3- (tert-butoxycarbonylamino) -2- hydroxyl -4-
Fenbutyramidum base) -4- methylpent acid esters be dissolved in 4- (dimercapto methylene) -2- methyl -6- (to dimethylaminostyryl) -
4H- pyrans (DCM), dropping trifluoroacetic acid (TFA), room temperature reaction 1.5~2.5h (preferably 2h), it is evaporated, adds water, with NaHCO3Molten
Liquid adjusts pH to 8.5~9.5 (preferably 9.0), and ethyl acetate extracts, and is dried, and filters, is evaporated to obtain colorless oil, by colorless oil
Thing with methyl alcohol as solvent, H2/ Pd-C environment is (in catalyst Pd-C and H2In the environment of) under react 4.5~5.5 (preferably 5h), mistake
Filter, concentrates, and standing filters, dry ubenimex, wherein (S)-phenyl 2- ((2S, 3R) -3- (tert-butoxycarbonylamino) -2- hydroxyl
Base -4- fenbutyramidum base) -4- methylpent acid esters:DCM:TFA=1:10~20:2~5, g:ml:g.
Room temperature reaction is overnight:Refer to that this day unit terminates the time to working continuation in second day.
Beneficial effects of the present invention:
1st, synthetic method of the present invention solves used resolving agent in existing synthetic method or toxicity too greatly (as Strychnos nux-vomica
Sub- alkali) or expensive (α-phenylethylamine) shortcoming, and synthetic method step is simple, low cost, avoids strychnia
Use Deng reagent.
2nd, the present invention adopts dextrorotation amino substance as hand-type resolving agent, and cheap, simple to operate, stirs, ties again
The brilliant time shortens, and substantially increases combined coefficient.
3rd, the present invention, with D-Boc- phenylpropyl alcohol ammonium aldehyde as initiation material, is synthesized ubenimex, synthetic route merely through 5 steps
Modern design, synthesis step is short, greatlys save production time and production cost, and midbody product is few, decreases discarded
The generation of thing and discharge, reduce the pollution to environment, more environmentally-friendly saving.
4th, while simplifying step, the synthesis yield of ubenimex can reach more than 87.3% to the present invention, and purity reaches
To more than 98.5%.
Brief description
The HPLC-UV detection of the ubenimex that Fig. 1 is prepared for the present invention.
Specific embodiment
With reference to embodiment, the invention will be further described.
Embodiment 1
The preparation of (2RS, 3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyronitrile (1):
36g (0.143mol) D-Boc- phenylpropyl alcohol ammonium aldehyde is dissolved in 100mL ethyl acetate, adds 400mL distilled water, 17.6g
(0.171mol) sodium hydrogensulfite, thin-layer chromatography (TLC) monitors the reaction mechanism mechanism of reaction, and reaction after 10h terminates, point water intaking phase, uses 300mL
Ethyl acetate is washed 2 times, adds 7.7g (0.157mol) Cymag to aqueous phase, and room temperature reaction overnight, is extracted with 300mL ethyl acetate
After 3 times, with 300mL wash 3 times, organic phase with anhydrous sodium sulfate drying 24h, be evaporated (2RS, 3R) -3- tert-butoxycarbonylamino -
2- hydroxy-4-phenyl butyronitrile (1) 27g, yield 68.5%.
The preparation of (2RS, 3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyric acid (2):
25g (0.09mol) (2RS, 3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyronitrile (1) is dissolved in 100mL
Isosorbide-5-Nitrae-dioxane, instills 100mL concentrated hydrochloric acid under ice bath, back flow reaction overnight, is evaporated, plus 100mL water dissolves, 100mL acetic acid
Ethyl ester is washed 3 times, with 3mol L-1Sodium hydroxide solution controls pH 11.0~12.0, and ice bath is cooled to 0 DEG C, is slowly added to 100mL
Containing 23.5g (0.108mol) dimethyl dicarbonate butyl ester (Boc)2The anhydrous tetrahydro furan (THF) of O, uses 1mol L simultaneously-1Hydrogen-oxygen
Change sodium solution and control pH 8.0~9.0, room temperature reaction overnight, keeps whole process pH 8.0~9.0, concentrates after completion of the reaction
Reactant liquor, is evaporated off THF, and 200mL petroleum ether washes 3 times, aqueous phase 1mol L-1HCl solution adjusts pH 2.0~3.0, uses 200mL
Ethyl acetate extracts three times, anhydrous sodium sulfate drying 24h, filters, and concentrates, recrystallized with ethyl acetate-hexane (2RS,
3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyric acid (2) 17.2g, yield 65.0%, (2S/2R=2:1).
The preparation of (2S, 3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyric acid (3):
17.0g (0.058mol) (2RS, 3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyric acid (2) is dissolved in
200mL absolute ethyl alcohol, adds 18.4g (0.087mol) (1S, 2S) -2- amino -1- (4- nitrobenzophenone) propane -1,3- glycol
(dextrorotation amino substance), lets cool crystallization after 60 DEG C of stirring 2h, filters, crystallization is dissolved in 100mL water, adjust PH 2.0 with 1N HCl solution
After~3.0 with 100mL ethyl acetate extract 3 times, be dried, filter, be evaporated, obtain (2S, 3R) -3- tert-butoxycarbonylamino -2- hydroxyl -
4-phenylbutyrate (3) 7.65g, yield 45.0%.
1.4 (S)-phenyl 2- ((2S, 3R) -3- (tert-butoxycarbonylamino) -2- hydroxyl -4- fenbutyramidum base) -4- methylpent
The preparation of acid esters (4):
6.0g (0.020mol) (2S, 3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyric acid (3) is dissolved in 100mL
4- (dimercapto methylene) -2- methyl -6- (to dimethylaminostyryl) -4H- pyrans (DCM), adds 3.0g under ice bath
(0.022mol) 1- hydroxy benzo triazole (HoBt), 4.54g (0.022mol) 1- ethyl-(3- dimethylaminopropyl) carbon two
Inferior amine salt hydrochlorate (EDCI), adds 8.65g (0.022mol) L-Leu benzyl ester tosilate, 3.0mL after half an hour
(0.022mol) triethylamine, room temperature reaction overnight, wash 3 times for 10% citric acid solution, 50mL saturation by 50mL mass concentration
NaHCO3Solution is washed 3 times, and the 50mL saturated common salt aqueous solution is washed 1 time, adds anhydrous magnesium sulfate to be dried overnight, filters, concentrate, places
Crystallize (S)-phenyl 2- ((2S, 3R) -3- (tert-butoxycarbonylamino) -2- hydroxyl -4- fenbutyramidum base) -4- methylpent acid esters
(4) 8.0g, yield 80%.
The synthesis of ubenimex
By 8.0g (0.016mol) (S)-phenyl 2- ((2S, 3R) -3- (tert-butoxycarbonylamino) -2- hydroxyl -4- fenbutyramidum
Base) -4- methylpent acid esters (4) are dissolved in 80mL4- (dimercapto methylene) -2- methyl -6- (to dimethylaminostyryl) -4H-
Pyrans (DCM), dropping 20mL trifluoroacetic acid (TFA), room temperature reaction 2h, it is evaporated, plus 50mL water, with saturation NaHCO3Adjust pH extremely
9.0,100mL ethyl acetate extract 3 times, are dried, and filter, are evaporated to obtain colorless oil, colorless oil is dissolved in absolute methanol,
Add 0.8g Pd-C, H2React 5h under environment, filter, concentrate, standing, filters, dry ubenimex 4.4g, yield
90.0%, purity 98.5%.
Embodiment 2
The preparation of (2RS, 3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyronitrile (1):
21.6g (0.0858mol) D-Boc- phenylpropyl alcohol ammonium aldehyde is dissolved in 43mL ethyl acetate, adds 173mL distilled water, 6.5g
(0.103mol) sodium hydrogensulfite, thin-layer chromatography (TLC) monitors the reaction mechanism mechanism of reaction, and reaction after 10h terminates, point water intaking phase, uses 300mL
Ethyl acetate is washed 2 times, adds 2.16g (0.094mol) Cymag to aqueous phase, and room temperature reaction overnight, is extracted with 300mL ethyl acetate
After taking 3 times, washed 3 times with 300mL, organic phase, with anhydrous sodium sulfate drying 24h, is evaporated the tertiary fourth oxanamide of (2RS, 3R) -3-
Base -2- hydroxy-4-phenyl butyronitrile (1) 15g, yield 63.4%.
The preparation of (2RS, 3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyric acid (2):
10g (0.036mol) (2RS, 3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyronitrile (1) is dissolved in 20mL
Isosorbide-5-Nitrae-dioxane, instills 16mL concentrated hydrochloric acid under ice bath, back flow reaction overnight, is evaporated, plus 100mL water dissolves, 40mL acetic acid second
Ester is washed 3 times, with 3mol L-1Sodium hydroxide solution controls pH 11.0~12.0, and ice bath is cooled to 0 DEG C, is slowly added to 40mL and contains
13g (0.059mol) dimethyl dicarbonate butyl ester (Boc)2The anhydrous tetrahydro furan (THF) of O, uses 1mol L simultaneously-1NaOH
Solution controls pH 8.0~9.0, and room temperature reaction overnight, keeps whole process pH 8.0~9.0, concentrates reaction after completion of the reaction
Liquid, is evaporated off THF, and 100mL petroleum ether washes 3 times, aqueous phase 1mol L-1HCl solution adjusts pH 2.0~3.0, with 80mL acetic acid second
Ester extracts three times, anhydrous sodium sulfate drying 24h, filters, and concentrates, recrystallizes (2RS, 3R) -3- uncle with ethyl acetate-hexane
Fourth oxanamide base -2- hydroxy-4-phenyl butyric acid (2) 6.1g, yield 57.6%, (2S/2R=2:1).
The preparation of (2S, 3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyric acid (3):
20.0g (0.068mol) (2RS, 3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyric acid (2) is dissolved in
160mL absolute ethyl alcohol, adds 20g (0.102mol) (1S, 2S) -2- amino -1- (4- nitrobenzophenone) propane -1, and 3- glycol is (right
Rotation amino substance, lets cool crystallization after 60 DEG C of stirring 2h, filters, crystallization is dissolved in 100mL water, with 1N HCl solution adjust PH 2.0~
Extracted 3 times with 100mL ethyl acetate after 3.0, be dried, filter, be evaporated, obtain (2S, 3R) -3- tert-butoxycarbonylamino -2- hydroxyl -4-
Phenylbutyric acid (3) 7.7g, yield 38.5%.
1.4 (S)-phenyl 2- ((2S, 3R) -3- (tert-butoxycarbonylamino) -2- hydroxyl -4- fenbutyramidum base) -4- methylpent
The preparation of acid esters (4):
10g (0.033mol) (2S, 3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyric acid (3) is dissolved in 100mL
4- (dimercapto methylene) -2- methyl -6- (to dimethylaminostyryl) -4H- pyrans (DCM), adds 2.0g under ice bath
(0.015mol) 1- hydroxy benzo triazole (HoBt), 3g (0.0146mol) 1- ethyl-(3- dimethylaminopropyl) carbon two is sub-
Amine hydrochlorate (EDCI), adds 10g (0.029mol) L-Leu benzyl ester tosilate, 2.0mL after half an hour
(0.0146mol) triethylamine, room temperature reaction overnight, wash 3 times for 10% citric acid solution, 50mL saturation by 50mL mass concentration
NaHCO3Solution is washed 3 times, and the 50mL saturated common salt aqueous solution is washed 1 time, adds anhydrous magnesium sulfate to be dried overnight, filters, concentrate, places
Crystallize (S)-phenyl 2- ((2S, 3R) -3- (tert-butoxycarbonylamino) -2- hydroxyl -4- fenbutyramidum base) -4- methylpent acid esters
(4) 13.0g, yield 78%.
The synthesis of ubenimex:
By 10.0g (0.020mol) (S)-phenyl 2- ((2S, 3R) -3- (tert-butoxycarbonylamino) -2- hydroxyl -4- benzene butyryl
Amido) -4- methylpent acid esters (4) be dissolved in 100mL4- (dimercapto methylene) -2- methyl -6- (to dimethylaminostyryl) -
4H- pyrans (DCM), dropping 20mL trifluoroacetic acid (TFA), room temperature reaction 2h, it is evaporated, plus 50mL water, with saturation NaHCO3Adjust pH
Extract 3 times to 9.0,100mL ethyl acetate, be dried, filter, be evaporated to obtain colorless oil, colorless oil is dissolved in no water beetle
Alcohol, adds 0.8g Pd-C, H2React 5h under environment, filter, concentrate, standing, filters, dry ubenimex 5.4g, yield
88.0%, purity 98.8%.
Embodiment 3
The preparation of (2RS, 3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyronitrile (1):
11g (0.043mol) D-Boc- phenylpropyl alcohol ammonium aldehyde is dissolved in 33mL ethyl acetate, adds 132mL distilled water, 8.8g
(0.052mol) sodium hydrogensulfite, thin-layer chromatography (TLC) monitors the reaction mechanism mechanism of reaction, and reaction after 10h terminates, point water intaking phase, uses 300mL
Ethyl acetate is washed 2 times, adds 4.4g (0.048mol) Cymag to aqueous phase, and room temperature reaction overnight, is extracted with 100mL ethyl acetate
After 3 times, with 100mL wash 3 times, organic phase with anhydrous sodium sulfate drying 24h, be evaporated (2RS, 3R) -3- tert-butoxycarbonylamino -
2- hydroxy-4-phenyl butyronitrile (1) 8g, yield 66%.
The preparation of (2RS, 3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyric acid (2):
17g (0.06mol) (2RS, 3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyronitrile (1) is dissolved in 68mL 1,
4- dioxane, instills 34mL concentrated hydrochloric acid under ice bath, back flow reaction overnight, is evaporated, plus 100mL water dissolves, 100mL ethyl acetate
Wash 3 times, with 3mol L-1Sodium hydroxide solution controls pH 11.0~12.0, and ice bath is cooled to 0 DEG C, is slowly added to 105mL and contains
17g (0.075mol) dimethyl dicarbonate butyl ester (Boc)2The anhydrous tetrahydro furan (THF) of O, uses 1mol L simultaneously-1NaOH
Solution controls pH 8.0~9.0, and room temperature reaction overnight, keeps whole process pH 8.0~9.0, concentrates reaction after completion of the reaction
Liquid, is evaporated off THF, and 100mL petroleum ether washes 3 times, aqueous phase 1mol L-1HCl solution adjusts pH 2.0~3.0, uses 100mL acetic acid
Ethyl ester extracts three times, anhydrous sodium sulfate drying 24h, filters, and concentrates, recrystallizes (2RS, 3R) -3- with ethyl acetate-hexane
Tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyric acid (2) 13g, yield 72.2%, (2S/2R=2:1).
The preparation of (2S, 3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyric acid (3):
30g (0.102mol) (2RS, 3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyric acid (2) is dissolved in 400mL
Absolute ethyl alcohol, adds 60g (0.142mol) (1S, 2S) -2- amino -1- (4- nitrobenzophenone) propane -1,3- glycol (dextrorotation amino
Thing, 60 DEG C stirring 2h after let cool crystallization, filter, crystallization is dissolved in 100mL water, with 1N HCl solution adjust PH 2.0~3.0 after with
100mL ethyl acetate extracts 3 times, is dried, and filters, is evaporated, obtains (2S, 3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl fourth
Sour (3) 13g, yield 43.3%.
1.4 (S)-phenyl 2- ((2S, 3R) -3- (tert-butoxycarbonylamino) -2- hydroxyl -4- fenbutyramidum base) -4- methylpent
The preparation of acid esters (4):
15g (0.050mol) (2S, 3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyric acid (3) is dissolved in 300mL
4- (dimercapto methylene) -2- methyl -6- (to dimethylaminostyryl) -4H- pyrans (DCM), adds 12g under ice bath
(0.088mol) 1- hydroxy benzo triazole (HoBt), 13.5g (0.022mol) 1- ethyl-(3- dimethylaminopropyl) carbon two
Inferior amine salt hydrochlorate (EDCI), adds 30g (0.034mol) L-Leu benzyl ester tosilate, 12mL after half an hour
(0.088mol) triethylamine, room temperature reaction overnight, wash 3 times for 10% citric acid solution, 50mL saturation by 50mL mass concentration
NaHCO3Solution is washed 3 times, and the 50mL saturated common salt aqueous solution is washed 1 time, adds anhydrous magnesium sulfate to be dried overnight, filters, concentrate, places
Crystallize (S)-phenyl 2- ((2S, 3R) -3- (tert-butoxycarbonylamino) -2- hydroxyl -4- fenbutyramidum base) -4- methylpent acid esters
(4) 20.0g, yield 80%.
The synthesis of ubenimex:
By 15.0g (0.030mol) (S)-phenyl 2- ((2S, 3R) -3- (tert-butoxycarbonylamino) -2- hydroxyl -4- benzene butyryl
Amido) -4- methylpent acid esters (4) be dissolved in 150mL4- (dimercapto methylene) -2- methyl -6- (to dimethylaminostyryl) -
4H- pyrans (DCM), dropping 75mL trifluoroacetic acid (TFA), room temperature reaction 2h, it is evaporated, plus 50mL water, with saturation NaHCO3Adjust pH
Extract 3 times to 9.0,100mL ethyl acetate, be dried, filter, be evaporated to obtain colorless oil, colorless oil is dissolved in no water beetle
Alcohol, adds 0.8g Pd-C, H2React 5h under environment, filter, concentrate, standing, filters, dry ubenimex 8g, yield
87.3%, purity 98.8%.
Detection test
Chromatographic condition and system suitability
It is filler (250mm × 4.6mm) with octadecylsilane chemically bonded silica;With acetonitrile:0.6%NaH2PO4(17:
83) it is mobile phase A;With acetonitrile:0.6%NaH2PO4(2:1) it is Mobile phase B;Flow velocity is 1.0ml per minute;Gradient elution;Detection
Wavelength is 210nm.Theoretical cam curve is calculated with ubenimex peak and should be not less than 5000, as seen from Figure 1, the inventive method institute
The final material of preparation is ubenimex.
Time | Mobile phase A (%) | Mobile phase B (%) |
0 | 100 | 0 |
20 | 100 | 0 |
50 | 0 | 100 |
70 | 0 | 100 |
70.01 | 100 | 0 |
85 | 100 | 0 |
Although above-mentioned be described to the specific embodiment of the present invention in conjunction with the embodiments, not the present invention is protected
The restriction of scope, one of ordinary skill in the art should be understood that on the basis of technical scheme, those skilled in the art
Do not need to pay the various modifications that creative work can make or deformation still within protection scope of the present invention.
Claims (10)
1. a kind of synthetic method of ubenimex is it is characterised in that comprise the following steps:
(1) preparation of hydroxyl nitrile:D-Boc- phenylpropyl alcohol ammonium aldehyde is dissolved in ethyl acetate, adds water, NaHSO3, react 8~15h, take
Aqueous phase, adds NaCN in aqueous phase, continues reaction 8~15h, with ethyl acetate extraction, washes, organic phase is dried, filter, be evaporated
Obtain (2RS, 3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyronitrile, described D-Boc- phenylpropyl alcohol ammonium aldehyde:Ethyl acetate:Water:
NaCN:NaHSO3=1:2~3:8~12:0.3~0.8:0.1~0.4, g:ml:ml:g:g;
(2) protection of itrile group hydrolysis and amino:(2RS, 3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyronitrile is added 2
The dioxane of~4 times amount and concentrated hydrochloric acid mixed liquor, described dioxane is 1 with the volume ratio of concentrated hydrochloric acid:0.8~2, backflow
Overnight, be dissolved in water after being evaporated, washed with ethyl acetate, adjust pH to 11~12, under ice bath dropping 4~6 times amount containing carbonic acid two
Tertiary butyl ester (Boc)2The tetrahydrofuran solution of O, described dimethyl dicarbonate butyl ester (Boc)2O:Oxolane=1:3~6, g:Ml,
After room temperature reaction 10~15h, THF is evaporated off, is washed with petroleum ether, adjust pH to 2~3, ethyl acetate extracts, be dried, filter, be evaporated,
Recrystallize (2RS, 3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyric acid;Described 2-4 times amount is:Dioxane with dense
Volume ml of hydrochloric acid mixed solution is 2-4 times of (2RS, 3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyronitrile quality g;Institute
Stating 4-6 times amount is:Dropping oxolane volume is 4-6 times of raw material D-Boc- phenylpropyl alcohol ammonium aldehyde weight g for raw material ml;
(3) chiral resolution of (2RS, 3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyric acid:By tertiary for (2RS, 3R) -3- fourth
Oxanamide base -2- hydroxy-4-phenyl butyric acid is dissolved in absolute ethyl alcohol, add (1S, 2S) -2- amino -1- (4- nitrobenzophenone) propane -
1,3- glycol, 50~70 DEG C stirring 1.5~2.5h after let cool crystallization, filter, by crystallization be dissolved in after water adjust pH to 2~3 after with
Ethyl acetate extracts, and is dried, and filters, is evaporated, obtains (2S, 3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyric acid, described
(2RS, 3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyric acid:Absolute ethyl alcohol:(1S, 2S) -2- amino -1- (4- nitrobenzene
Base) propane -1,3- glycol=1:8~13:1~2, g:ml:g;
(4) (S)-phenyl 2- ((2S, 3R) -3- (tert-butoxycarbonylamino) -2- hydroxyl -4- fenbutyramidum base) -4- methylpent acid esters
Synthesis:By (2S, 3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyric acid be dissolved in 4- (dimercapto methylene) -2- methyl -
6- (to dimethylaminostyryl) -4H- pyrans or anhydrous methylene chloride, add 1- hydroxy benzo triazole, 1- second under ice bath
Base-(3- dimethylaminopropyl) carbodiimide hydrochloride, adds L-Leu benzyl ester tosilate after 20~40min
And triethylamine, room temperature reaction overnight, with mass fraction for 10% citric acid, saturation NaHCO3, saturated common salt is washed, and is dried, mistake
Filter, is evaporated (S)-phenyl 2- ((2S, 3R) -3- (tert-butoxycarbonylamino) -2- hydroxyl -4- fenbutyramidum base) -4- methylvaleric acid
Ester, described (2S, 3R) -3- tert-butoxycarbonylamino -2- hydroxy-4-phenyl butyric acid:4- (dimercapto methylene) -2- methyl -6- is (right
Dimethylaminostyryl) -4H- pyrans:1- hydroxy benzo triazole:1- ethyl-(3- dimethylaminopropyl) carbodiimide
Hydrochloride:L-Leu benzyl ester tosilate:Triethylamine=1:10~20:0.2~0.8:0.3~0.9:1~2:0.2~
0.8, g:ml:g:g:g:ml;
(5) synthesis of ubenimex:By (S)-phenyl 2- ((2S, 3R) -3- (tert-butoxycarbonylamino) -2- hydroxyl -4- benzene butyryl
Amido) -4- methylpent acid esters are dissolved in 4- (dimercapto methylene) -2- methyl -6- (to dimethylaminostyryl) -4H- pyrans,
Dropping trifluoroacetic acid room temperature reaction 1.5~2.5h, is evaporated, adds water, and adjusts pH to 8.5~9.5, and ethyl acetate extracts, and is dried, mistake
Filter, is evaporated to obtain colorless oil, by colorless oil with methyl alcohol as solvent, H24.5~5.5h, mistake is reacted under/Pd-C environment
Filter, concentrates, and standing filters, dry ubenimex, described (S)-phenyl 2- ((2S, 3R) -3- (tert-butoxycarbonylamino) -2-
Hydroxyl -4- fenbutyramidum base) -4- methylpent acid esters:4- (dimercapto methylene) -2- methyl -6- is (to dimethylamino styrene
Base) -4H- pyrans:Trifluoroacetic acid=1:10~20:2~5, g:ml:g.
2. synthetic method as claimed in claim 1 is it is characterised in that D-Boc- phenylpropyl alcohol ammonium aldehyde is dissolved in second by described step (1)
Acetoacetic ester, adds water, NaHSO3, 10h, phase of fetching water, add NaCN in aqueous phase, continue reaction 10h.
3. synthetic method as claimed in claim 1 is it is characterised in that use 3N NaOH solution to adjust pH extremely in described step (2)
11~12.
4. synthetic method as claimed in claim 1 is it is characterised in that after room temperature reaction 12h in described step (2), be evaporated off
THF, is washed with petroleum ether, and 1N HCl adjusts pH to 2~3.
5. synthetic method as claimed in claim 1 is it is characterised in that let cool crystallization after 60 DEG C of stirring 2h in described step (3).
6. synthetic method as claimed in claim 1 uses 1N it is characterised in that crystallization is dissolved in after water in described step (3)
HCl adjusts PH to 2~3.
7. the synthetic method as described in claim 1 is it is characterised in that by tertiary for (2S, 3R) -3- fourth oxygen in described step (4)
Amide groups -2- hydroxy-4-phenyl butyric acid be dissolved in 4- (dimercapto methylene) -2- methyl -6- (to dimethylaminostyryl) -
4H- pyrans, addition 1- hydroxy benzo triazole under ice bath, 1- ethyl-(3- dimethylaminopropyl) carbodiimide hydrochloride,
L-Leu benzyl ester tosilate and triethylamine is added after 30min.
8. synthetic method as claimed in claim 1 is it is characterised in that drip trifluoroacetic acid room temperature reaction in described step (5)
2h.
9. synthetic method as claimed in claim 1 is it is characterised in that with NaHCO in described step (5)3Solution adjusts pH extremely
9.0.
10. synthetic method as claimed in claim 1 is it is characterised in that H in described step (5)25h is reacted under/Pd-C environment.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410742120.9A CN104496843B (en) | 2014-12-08 | 2014-12-08 | Method for synthesizing ubenimex |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410742120.9A CN104496843B (en) | 2014-12-08 | 2014-12-08 | Method for synthesizing ubenimex |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104496843A CN104496843A (en) | 2015-04-08 |
CN104496843B true CN104496843B (en) | 2017-02-22 |
Family
ID=52938317
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410742120.9A Active CN104496843B (en) | 2014-12-08 | 2014-12-08 | Method for synthesizing ubenimex |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104496843B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112341356B (en) * | 2019-08-09 | 2023-04-28 | 成都苑东生物制药股份有限公司 | (2S, 3R) -3-amino-2-hydroxy-4-phenylbutyramide derivative, preparation method and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2035800A1 (en) * | 1991-09-27 | 1993-04-16 | Marga Investigacion | 2-Substd.-4-phenyl-butyric acids |
CN101891647A (en) * | 2010-03-15 | 2010-11-24 | 浙江普洛康裕制药有限公司 | Preparation method for ubenimex |
-
2014
- 2014-12-08 CN CN201410742120.9A patent/CN104496843B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2035800A1 (en) * | 1991-09-27 | 1993-04-16 | Marga Investigacion | 2-Substd.-4-phenyl-butyric acids |
CN101891647A (en) * | 2010-03-15 | 2010-11-24 | 浙江普洛康裕制药有限公司 | Preparation method for ubenimex |
Non-Patent Citations (2)
Title |
---|
N. Gogoi等.A total synthesis of (-)-bestatin using Shibasaki’s asymmetric Henry reaction.《Tetrahedron Letters》.2005,第46卷第7581–7582页. * |
Preparation of a-Hydroxy-b-Fmoc Amino Acids from N-Boc Amino Acids;Erik P. Johnson等;《SYNTHESIS》;20111103(第24期);第4023–4026页 * |
Also Published As
Publication number | Publication date |
---|---|
CN104496843A (en) | 2015-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10407403B2 (en) | Preparation method of cobimetinib | |
CN108395443B (en) | Cyclic compounds inhibiting programmed death receptor ligand 1 and uses thereof | |
CN103012551B (en) | Synthetic method of high-purity bortezomib and intermediate thereof | |
CN107216313B (en) | A kind of preparation method of anti-tumor drug AZD9291 | |
CN105085322A (en) | Preparation method and intermediate of AHU-377 intermediate and preparation method of intermediate | |
CN103435532A (en) | Synthetic method of boceprevir intermediate | |
CN104356012B (en) | The preparation method of sarpogrelate hydrochloride light degradation impurity | |
CN106349185A (en) | Amino-protected 3-hydroxy adamantane glycine benzothiazole-2-thiol active ester as well as preparation method and application thereof | |
CN103360374B (en) | The synthetic method of vilazodone and salt thereof | |
CN105693605B (en) | A kind of method of asymmetric synthesis of optical voidness (R)/(S) chloroquine | |
CN105130999A (en) | Synthesis method of Sitagliptin impurities | |
CN104496843B (en) | Method for synthesizing ubenimex | |
CN102718768B (en) | Chiral five-membered bicyclic guanidine compound, preparation method and application thereof | |
CN112110897B (en) | Preparation method of deuterated crizotinib and derivative thereof | |
CN107602559A (en) | A kind of method of the asymmetric ciprofloxacin eye drops synthesis of chiral ternary carbocyclic nucleoside triggered by Michael's addition | |
CN103864889A (en) | Epoxy ketone compound, preparation method thereof and preparation method of kyprolis | |
CN105330558A (en) | Compound and method for producing same, as well as method for producing oseltamivir phosphate | |
CN104771392A (en) | Histone deacetylase inhibitor and applications thereof | |
CN105693606A (en) | Asymmetric synthesis method of optically pure (R)/(S)-hydroxychloroquine | |
CN105646284A (en) | Lacosamide synthesis method | |
CN102796106B (en) | A kind of pemetrexed method of quality control and pemetrexed impurity and the preparation of salt thereof | |
CN106083689A (en) | A kind of new preparation process of Silodosin compound | |
CN105801438A (en) | Synthetic method of mirabegron intermediate | |
CN105218519A (en) | A kind of preparation method of dabigatran etexilate intermediate | |
CN105669475A (en) | Preparation method of dapoxetine and dapoxetine hydrochloride |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |